Fly News Breaks for November 25, 2019
TDOC
Nov 25, 2019 | 04:53 EDT
Stifel analyst David Grossman initiated coverage of Teladoc Health with a Hold rating and $83 price target. The analyst believes the company's near-term revenue growth targets are reasonable, but his neutral rating reflects valuation and "some lack of visibility on how margins evolve over time." He prefers an entry point with a more attractive risk/reward profile.
News For TDOC From the Last 2 Days
There are no results for your query TDOC